News | Magnetic Resonance Imaging (MRI) | October 23, 2018

Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment

New study finds carotid artery plaque revealed on MRI may be better indicator of cardiovascular disease than ultrasound-based carotid intima-media thickness test

Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment

October 23, 2018 — Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease risk assessment, according to a new study appearing in the journal Radiology.1

The carotid arteries are the two major arteries on either side of the neck that carry blood into the head and brain. Like the coronary arteries, they can become narrowed with plaque buildup, a process known as atherosclerosis. Research has shown that plaque buildup in the carotid arteries often mirrors that in the coronary arteries, but the carotids are more easily imaged, making them potentially useful vessels for the assessment of the risk of strokes, heart attacks and other adverse cardiovascular events.

"The carotid artery serves as window into the cardiovascular system," said study lead author Bruce A. Wasserman, M.D., from Johns Hopkins University School of Medicine in Baltimore. "Plaque developing in the carotid artery can contribute directly to a stroke, and its features — which determine its vulnerability to rupture — are closely related to those found in coronary artery plaque in the same patients."

The ultrasound-based carotid intima-media thickness (IMT) test is the most widely used imaging method to assess the level of early-stage carotid atherosclerosis. However, research suggests that IMT offers only minor improvement in cardiovascular disease risk prediction when added to the Framingham risk score, a commonly used measure that takes into account factors like cholesterol, smoking and family history.

Vessel wall MRI is a promising, noninvasive technique that can image the entire carotid wall circumference, in contrast to ultrasound measurements of IMT that are usually based solely on views of the artery's far wall. MRI can also see all three layers of the artery, including the adventitia, the outermost layer not visible on IMT.

"High-resolution MRI can tell us the stage of plaque in the wall and tell us about plaque features that could lead to stroke," Wasserman said. "It can also see the adventitia, a vessel layer that may have an important role in cardiovascular risk because small vessels proliferate there, leading to thickening of the artery, which may be responsible for early disease development and progression."

From July 2000 to December 2013, the researchers enrolled 698 men and women from the Multi-Ethnic Study of Atherosclerosis (MESA), a long-running project involving six major research centers around the U.S. Study participants ranged in age from 45 to 84 years old, with a mean age of 63 at first visit, and no known history of cardiovascular disease. The participants underwent ultrasound and MRI between 2000 and 2004 to compare carotid artery wall thickness. During subsequent follow-up, the researchers looked for any correlation between carotid artery wall thickness measurements and coronary heart disease and stroke.

"What we saw was surprising," Wasserman said. "MRI measures of carotid artery wall thickness were more consistently associated with cardiovascular events than was intima-media thickness using ultrasound. This tells us that perhaps MRI could be a better predictor of cardiovascular events, especially stroke."

The association between wall thickness and cardiovascular events was stronger with both non-contrast and contrast-enhanced MRI than it was for IMT.

Wasserman cautioned that more research is needed to define how much MRI can add to the predictive models currently in use. MRI is expensive and would be impractical as a stand-alone measure of cardiovascular risk, but it could have a role in providing critical supplementary information for some patients.

"We've come a long way with MRI techniques and their ability to discriminate the carotid artery wall and assess adventitia thickness," he said. "Ultrasound has also improved, and we want to be able study cardiovascular risk and carotid artery thickness using these contemporary techniques."

Further studies are planned with the newer technology and in larger population groups.

For more information: www.pubs.rsna.org/journal/radiology

Reference

1. Zhang Y., Guallar E., Malhotra S., et al. Carotid Artery Wall Thickness and Incident Cardiovascular Events: A Comparison between US and MRI in the Multi-Ethnic Study of Atherosclerosis (MESA). Radiology, Oct. 9, 2018. https://doi.org/10.1148/radiol.2018173069

 

Related Content

U.S. Soldiers Have Worse Heart Health Than Civilians
News | Cardiac Diagnostics | June 06, 2019
Active duty Army personnel have worse cardiovascular health compared to people of similar ages in the civilian...
Late Dinner and No Breakfast Worsens Outcomes After Heart Attack
News | Cardiac Diagnostics | May 23, 2019
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack, according to research...
HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy
News | Cardiac Diagnostics | May 14, 2019
The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement with guidance on the evaluation and...
New Best Practices Help Manage Heart Attack Patients Without Significant Signs
News | Cardiac Diagnostics | April 15, 2019
For the first time in the United States, doctors with the American Heart Association (AHA) have outlined best practices...
The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes.

The most recent U.S. Food and Drug Administration (FDA) clearance was Siemens Healthineers high-sensitivity troponin I assays (TnIH) for the Atellica IM and ADVIA Centaur XP/XPT in vitro diagnostic analyzers. The test helps in the early diagnosis of myocardial infarctions without the need for serial tropic testing. The time to first results is 10 minutes. 

Feature | Cardiac Diagnostics | March 22, 2019 | Linda C. Rogers, Ph.D.
Troponins are a family of proteins found in skeletal and heart (cardiac) muscle fibers that produce muscular contract
ACC/AHA Update Guidance for Preventing Heart Disease; Stroke
Feature | Cardiac Diagnostics | March 18, 2019
The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a heart healthy...
AHA Statement Warns Hookah Smoking May Harm the Heart
News | Cardiac Diagnostics | March 08, 2019
Smoking tobacco in waterpipes, more commonly known as hookahs, results in inhaling toxic chemicals, often at levels...
PTSD Alone Does Not Increase Heart Disease Risk in Veterans
News | Cardiac Diagnostics | February 20, 2019
February 20, 2019 — Post-traumatic stress disorder (PTSD) by itself does not explain the...
Hormone Therapy May Increase Cardiovascular Risk During Gender Transition
News | Cardiac Diagnostics | February 18, 2019
Patients receiving hormone therapy as part of their gender-transition treatment had an elevated risk for cardiovascular...
Overlay Init